Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

The global molecular cytogenetics market size is calculated at USD 2.78 billion in 2025 and is expected to reach around USD 6 ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 88 tables and 75 figures, this 196-page report ?Asia Pacific Active Pharmaceutical Ingredients (API) Market 2022-2032 by ...

Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, d riven by rising adoption of biologics in disease management, ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...